Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/01/23
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 11/20/12
End: 07/14/22
Due: 07/14/23
Phase: N/A
Priority: Normal
Start: 06/01/16
End: 12/31/23
Due: 12/31/24
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Study on the Composite Endpoint Event of PCSK9 Inhibitor in Patients With Very High Risk of ASCVD and Cancer | NCT05976893 | Xiang Xie | user2@example.com | None | 2023-08-01 | 2025-12-31 | 2026-12-31 | - | - | 2025-07-14 |
| Cohort Study of Chronic Heart Failure | NCT06092658 | Xiang Xie | user2@example.com | None | 2012-11-20 | 2022-07-14 | 2023-07-14 | - | - | 2025-07-14 |
| Prognosis of Treated Acute Coronary Syndrome Patients: a Multicenter Study | NCT05164601 | Xiang Xie | user2@example.com | None | 2016-06-01 | 2023-12-31 | 2024-12-31 | - | - | 2025-07-14 |